文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

2019 年全球痴呆症成本。

The worldwide costs of dementia in 2019.

机构信息

Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Solna, Sweden.

World Health Organization, Geneva, Switzerland.

出版信息

Alzheimers Dement. 2023 Jul;19(7):2865-2873. doi: 10.1002/alz.12901. Epub 2023 Jan 8.


DOI:10.1002/alz.12901
PMID:36617519
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10842637/
Abstract

INTRODUCTION: Dementia is a leading cause of death and disability globally. Estimating total societal costs demonstrates the wide impact of dementia and its main direct and indirect economic components. METHODS: We constructed a global cost model for dementia, presenting costs as cumulated global and regional costs. RESULTS: In 2019, the annual global societal costs of dementia were estimated at US $1313.4 billion for 55.2 million people with dementia, corresponding to US $23,796 per person with dementia. Of the total, US $213.2 billion (16%) were direct medical costs, US $448.7 billion (34%) direct social sector costs (including long-term care), and US $651.4 billion (50%) costs of informal care. DISCUSSION: The huge costs of dementia worldwide place enormous strains on care systems and families alike. Although most people with dementia live in low- and middle-income countries, highest total and per-person costs are seen in high-income countries. HIGHLIGHTS: Global economic costs of dementia were estimated to reach US $1313.4 in 2019. Sixty-one percent of people with dementia live in low-and middle-income countries, whereas 74% of the costs occur in high-income countries. The impact of informal care accounts for about 50% of the global costs. The development of a long-term care infrastructure is a great challenge for low-and middle-income countries. There is a great need for more cost studies, particularly in low- and middle-income countries. Discussions of a framework for global cost comparisons are needed.

摘要

简介:痴呆症是全球主要的死亡和残疾原因。估计全社会成本可以说明痴呆症及其主要直接和间接经济构成部分的广泛影响。

方法:我们构建了一个全球痴呆症成本模型,呈现出累积的全球和区域成本。

结果:2019 年,全球 5520 万痴呆症患者的年度全社会痴呆症成本估计为 1.3134 万亿美元,相当于每位痴呆症患者 23796 美元。其中,2132 亿美元(16%)为直接医疗费用,4487 亿美元(34%)为直接社会部门费用(包括长期护理),6514 亿美元(50%)为非正式护理费用。

讨论:痴呆症给全球的护理系统和家庭带来了巨大的负担。尽管大多数痴呆症患者生活在中低收入国家,但高收入国家的总费用和人均费用最高。

重点:2019 年全球痴呆症经济成本估计达到 13134 亿美元。61%的痴呆症患者生活在中低收入国家,而 74%的费用发生在高收入国家。非正式护理的影响约占全球成本的 50%。为中低收入国家建立长期护理基础设施是一个巨大的挑战。特别需要在中低收入国家进行更多的成本研究。需要讨论全球成本比较的框架。

相似文献

[1]
The worldwide costs of dementia in 2019.

Alzheimers Dement. 2023-7

[2]
The worldwide costs of dementia 2015 and comparisons with 2010.

Alzheimers Dement. 2017-1

[3]
The worldwide economic impact of dementia 2010.

Alzheimers Dement. 2013-1

[4]
The societal costs of dementia in Sweden 2012 - relevance and methodological challenges in valuing informal care.

Alzheimers Res Ther. 2016-11-18

[5]
Societal Costs of Dementia: 204 Countries, 2000-2019.

J Alzheimers Dis. 2024

[6]
The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.

Tob Use Insights. 2015-7-14

[7]
The cost of dementia in an unequal country: The case of Chile.

PLoS One. 2017-3-7

[8]
The worldwide societal costs of dementia: Estimates for 2009.

Alzheimers Dement. 2010-3

[9]
An estimate of the total worldwide societal costs of dementia in 2005.

Alzheimers Dement. 2007-4

[10]
Costs of Dementia in Low- And Middle-Income Countries: A Systematic Review.

J Alzheimers Dis. 2023

引用本文的文献

[1]
Association between weekend recovery sleep and risk of incident dementia: a prospective cohort study in the UK Biobank.

J Neurol. 2025-9-5

[2]
Wealth, income and dementia in Germany: longitudinal findings from a representative survey among the oldest old.

BMC Public Health. 2025-8-29

[3]
A Narrative Review on the Neuroprotective Effects of Selenium and Vitamin D in Alzheimer's Disease.

Biol Trace Elem Res. 2025-8-14

[4]
Circulating Biomarkers for the Early Diagnosis of Alzheimer's Disease.

Int J Mol Sci. 2025-7-27

[5]
The feasibility of the virtually delivered dementia lifestyle intervention for getting healthy together (DELIGHT) program for people living with dementia and their family/friend care partners.

PLoS One. 2025-8-12

[6]
How Healthy and Unhealthy Lifestyle Behaviors Affect Cognitive Function-Evidence From Older Adults in Chinese Communities: Cross-Sectional Study.

JMIR Public Health Surveill. 2025-8-12

[7]
The Mediating Effect of Smoking on the Association between Income and Dementia among Japanese Older People.

JMA J. 2025-7-15

[8]
Cascaded Multimodal Deep Learning in the Differential Diagnosis, Progression Prediction, and Staging of Alzheimer's and Frontotemporal Dementia.

medRxiv. 2025-7-21

[9]
Strengthening Africa's brain health and economic resilience.

Nat Med. 2025-8-7

[10]
Cognitive and neuropsychological trajectories in patients with mixed neurodegenerative pathologies.

Alzheimers Dement. 2025-8

本文引用的文献

[1]
Costs of Dementia in Low- And Middle-Income Countries: A Systematic Review.

J Alzheimers Dis. 2023

[2]
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.

Lancet Public Health. 2022-2

[3]
Beyond the project: Building a strategic theory of change to address dementia care, treatment and support gaps across seven middle-income countries.

Dementia (London). 2022-1

[4]
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.

Lancet. 2020-10-17

[5]
The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study.

Lancet Diabetes Endocrinol. 2017-4-26

[6]
The worldwide costs of dementia 2015 and comparisons with 2010.

Alzheimers Dement. 2017-1

[7]
How to deal with missing longitudinal data in cost of illness analysis in Alzheimer's disease-suggestions from the GERAS observational study.

BMC Med Res Methodol. 2016-7-18

[8]
Guidance for conducting systematic scoping reviews.

Int J Evid Based Healthc. 2015-9

[9]
Methodological quality and reporting of generalized linear mixed models in clinical medicine (2000-2012): a systematic review.

PLoS One. 2014-11-18

[10]
Comparison of informal care time and costs in different age-related dementias: a review.

Biomed Res Int. 2012-12-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索